ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for ACADIA Pharmaceuticals in a research report ...
We also announced several executive leadership changes, and as we look ahead to our 150th anniversary this year, Prudential (PRU) is well positioned to continue to deliver long-term, sustainable ...